Top 5 Stock Picks of Farallon Capital

2. Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Farallon Capital Equity Stake: $124.61 Million
Number of Hedge Fund Holders: 34 

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is a clinical-stage biopharmaceutical company that develops novel peptide-based drugs for haematology and blood disorders and inflammatory and immunomodulatory diseases.

Farallon Capital participated in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)’s $100 million financing in 2021. Protagonist is up by about 27%, affirming its status as one of Farallon Capital’s top stock picks in the healthcare sector. The hedge fund owns $124.61 million worth of stakes in Protagonist Therapeutics, Inc. (NASDAQ:PTGX), having bought stakes in the company in 2017 for the first time.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) saw a significant increase in hedge fund interest in the second quarter, according to Insider Monkey’s database. The number of bullish hedge funds rose from 23 in the previous quarter to 34 in the second quarter.

Follow Protagonist Therapeutics Inc

[/company-follow-email]